-
1 Comment
Evolent Health, Inc is currently in a long term uptrend where the price is trading 21.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Evolent Health, Inc's total revenue rose by 15.0% to $272M since the same quarter in the previous year.
Its net income has increased by 92.6% to $-15M since the same quarter in the previous year.
Finally, its free cash flow fell by 571.7% to $-19M since the same quarter in the previous year.
Based on the above factors, Evolent Health, Inc gets an overall score of 4/5.
Industry | Health Information Services |
---|---|
Sector | Healthcare |
ISIN | US30050B1017 |
CurrencyCode | EUR |
Exchange | F |
Market Cap | 3B |
---|---|
PE Ratio | None |
Beta | 1.56 |
Dividend Yield | 0.0% |
Target Price | 28.33 |
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 9EH.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024